Product Name
CD35, C3b (CR1), Monoclonal Antibody
Full Product Name
CD35, C3b (CR1, Follicular Dendritic Cell Marker)
Product Synonym Names
Anti -CD35, C3b (CR1, Follicular Dendritic Cell Marker)
Product Gene Name
anti-CR1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 1; NC_000001.10 (207669473..207815110). Location: 1q32
3D Structure
ModBase 3D Structure for P17927
Specificity
Recognizes a single epitope of CR1.
Purity/Purification
Affinity Purified
Purified
Form/Format
Supplied as a liquid in PBS, 0.1% BSA, 0.02% sodium azide.
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-CR1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CR1 antibody
CD35 (CR1) is a type 1 membrane glycoprotein participating in clearance of immune complexes, regulation of autologous complement activation on cell surfaces, and complement- dependent cellular cytotoxicity mediated by leukocytes. CD35 inhibits complement activation by two distinct mechanisms. CD35 is a cofactor for factor I cleavage of C3b, iC3b and C4b. Furthermore CD35 mediates decay-dissociation of C3 and C5 convertases. CD35 is found on erythrocytes, neutrophils, monocytes and dendritic cells. There are four allotypic variants of CR35 (CR1) with different molecular masses: 190kD (CR-1A), 220kD (CR1-B), 160kD (CR1-C) and 250kD (CR1-D).
Product Categories/Family for anti-CR1 antibody
Antibodies; Abs to CD Markers
Applications Tested/Suitable for anti-CR1 antibody
Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC), Flow Cytometry (FC/FACS)
Application Notes for anti-CR1 antibody
Dilution: Flow Cytometry: 1:10
Western Blot: 1:10
Immunohistochemistry: 1:10
Immunoprecipitation: 1:10
NCBI/Uniprot data below describe general gene information for CR1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_000642.3
[Other Products]
NCBI GenBank Nucleotide #
NM_000651.4
[Other Products]
UniProt Primary Accession #
P17927
[Other Products]
UniProt Secondary Accession #
Q16744; Q16745; Q5SR43; Q5SR45; Q9UQV2[Other Products]
UniProt Related Accession #
P17927[Other Products]
Molecular Weight
223,663 Da[Similar Products]
NCBI Official Full Name
complement receptor type 1 isoform S
NCBI Official Synonym Full Names
complement component (3b/4b) receptor 1 (Knops blood group)
NCBI Official Symbol
CR1 [Similar Products]
NCBI Official Synonym Symbols
KN; C3BR; C4BR; CD35
[Similar Products]
NCBI Protein Information
complement receptor type 1; CD35 antigen; C3b/C4b receptor; C3-binding protein; Knops blood group antigen
UniProt Protein Name
Complement receptor type 1
UniProt Synonym Protein Names
C3b/C4b receptor
Protein Family
Complement receptor
UniProt Gene Name
CR1 [Similar Products]
UniProt Synonym Gene Names
C3BR [Similar Products]
UniProt Entry Name
CR1_HUMAN
NCBI Summary for CR1
This gene is a member of the receptors of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants, encoding different isoforms, have been characterized. Additional allele specific isoforms, including a secreted form, have been described but have not been fully characterized. [provided by RefSeq, Jul 2008]
UniProt Comments for CR1
CR1: Mediates cellular binding of particles and immune complexes that have activated complement. Belongs to the receptors of complement activation (RCA) family.
Protein type: Membrane protein, integral; Receptor, misc.
Chromosomal Location of Human Ortholog: 1q32
Cellular Component: cell surface; integral to plasma membrane; plasma membrane
Molecular Function: complement component C4b binding; complement component C3b receptor activity; complement component C4b receptor activity; complement component C3b binding
Biological Process: negative regulation of complement activation, alternative pathway; complement receptor mediated signaling pathway; negative regulation of complement activation, classical pathway; regulation of complement activation; innate immune response; complement activation, classical pathway
Disease: Knops Blood Group System; Malaria, Susceptibility To
Research Articles on CR1
1. The CD35 antigen bounds gp350/220 and became latently infected when the fusion receptor HLA II was coexpressed.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.